These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22941199)

  • 41. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
    Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
    Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
    Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
    Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
    Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
    Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
    Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
    Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
    Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
    Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
    Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of pancreatic cancer peripheral blood by comparative proteomics].
    Chen J; Wu W; Tang HK; Zheng CS; Xia YL; Zhou HC; Yang RB; Chen LJ; Hu LW
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):62-5. PubMed ID: 23578431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.
    Jin XL; Xu B; Wu YL
    World J Gastroenterol; 2014 Oct; 20(40):14958-64. PubMed ID: 25356057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.
    Huang TL; Cho YT; Su H; Shiea J
    Clin Chim Acta; 2013 Sep; 424():175-81. PubMed ID: 23778025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of SELDI-TOF MS technology analyzing serum protein profiling for distinguishing laryngeal carcinoma from ordinary people].
    Zhang X; Chen Y; Wang J; Qu X; Deng B; Wang J; Xie G; Li M; Xu F
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):842-6. PubMed ID: 17144495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The application of surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in diagnosing dysplasia and chronic atrophic gastric-carditis in population with high risk of gastric-cardia adenocarcinoma].
    Wang DC; Wang LD; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):573-6. PubMed ID: 16194406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
    Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
    Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.